| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABL2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
|
AFDN
|
afadin, adherens junction formation factor
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ARF6
|
ADP-ribosylation factor 6
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BCL2L1
|
BCL2-like 1
|
|
BRAP
|
BRCA1 associated protein
|
|
BUB1B-PAK6
|
BUB1B-PAK6 readthrough
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CALM2
|
calmodulin 2 (phosphorylase kinase, delta)
|
|
CALM3
|
calmodulin 3 (phosphorylase kinase, delta)
|
|
CALML3
|
calmodulin-like 3
|
|
CALML4
|
calmodulin-like 4
|
|
CALML5
|
calmodulin-like 5
|
|
CALML6
|
calmodulin-like 6
|
|
CDC42
|
cell division cycle 42
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
EGFR
|
epidermal growth factor receptor
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
EPHA2
|
EPH receptor A2
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2
|
|
EXOC2
|
exocyst complex component 2
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FOXO4
|
forkhead box O4
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GNB1
|
guanine nucleotide binding protein (G protein), beta polypeptide 1
|
|
GNB2
|
guanine nucleotide binding protein (G protein), beta polypeptide 2
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GNB4
|
guanine nucleotide binding protein (G protein), beta polypeptide 4
|
|
GNB5
|
guanine nucleotide binding protein (G protein), beta 5
|
|
GNG10
|
guanine nucleotide binding protein (G protein), gamma 10
|
|
GNG11
|
guanine nucleotide binding protein (G protein), gamma 11
|
|
GNG12
|
guanine nucleotide binding protein (G protein), gamma 12
|
|
GNG13
|
guanine nucleotide binding protein (G protein), gamma 13
|
|
GNG2
|
guanine nucleotide binding protein (G protein), gamma 2
|
|
GNG3
|
guanine nucleotide binding protein (G protein), gamma 3
|
|
GNG4
|
guanine nucleotide binding protein (G protein), gamma 4
|
|
GNG5
|
guanine nucleotide binding protein (G protein), gamma 5
|
|
GNG7
|
guanine nucleotide binding protein (G protein), gamma 7
|
|
GNG8
|
guanine nucleotide binding protein (G protein), gamma 8
|
|
GNGT1
|
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1
|
|
GNGT2
|
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HTR7
|
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
INSR
|
insulin receptor
|
|
JMJD7-PLA2G4B
|
JMJD7-PLA2G4B readthrough
|
|
KDR
|
kinase insert domain receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KSR1
|
kinase suppressor of ras 1
|
|
KSR2
|
kinase suppressor of ras 2
|
|
LAT
|
linker for activation of T cells
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK10
|
mitogen-activated protein kinase 10
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MRAS
|
muscle RAS oncogene homolog
|
|
NF1
|
neurofibromin 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NGFR
|
nerve growth factor receptor
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PAK3
|
p21 protein (Cdc42/Rac)-activated kinase 3
|
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4
|
|
PAK5
|
p21 (RAC1) activated kinase 5
|
|
PAK6
|
p21 protein (Cdc42/Rac)-activated kinase 6
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PIK3R2
|
phosphoinositide-3-kinase, regulatory subunit 2 (beta)
|
|
PIK3R3
|
phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
|
|
PLA1A
|
phospholipase A1 member A
|
|
PLA2G10
|
phospholipase A2, group X
|
|
PLA2G12A
|
phospholipase A2, group XIIA
|
|
PLA2G12B
|
phospholipase A2, group XIIB
|
|
PLA2G1B
|
phospholipase A2, group IB (pancreas)
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLA2G2C
|
phospholipase A2, group IIC
|
|
PLA2G2D
|
phospholipase A2, group IID
|
|
PLA2G2E
|
phospholipase A2, group IIE
|
|
PLA2G2F
|
phospholipase A2, group IIF
|
|
PLA2G3
|
phospholipase A2, group III
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLA2G4B
|
phospholipase A2, group IVB (cytosolic)
|
|
PLA2G4C
|
phospholipase A2, group IVC (cytosolic, calcium-independent)
|
|
PLA2G4D
|
phospholipase A2, group IVD (cytosolic)
|
|
PLA2G4E
|
phospholipase A2, group IVE
|
|
PLA2G4F
|
phospholipase A2, group IVF
|
|
PLA2G5
|
phospholipase A2, group V
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PLAAT3
|
phospholipase A and acyltransferase 3
|
|
PLCE1
|
phospholipase C, epsilon 1
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLD2
|
phospholipase D2
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta
|
|
PRKACG
|
protein kinase, cAMP-dependent, catalytic, gamma
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCG
|
protein kinase C, gamma
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
RAB5A
|
RAB5A, member RAS oncogene family
|
|
RAB5B
|
RAB5B, member RAS oncogene family
|
|
RAB5C
|
RAB5C, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
|
|
RAC3
|
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RALA
|
v-ral simian leukemia viral oncogene homolog A (ras related)
|
|
RALB
|
v-ral simian leukemia viral oncogene homolog B
|
|
RALBP1
|
ralA binding protein 1
|
|
RALGDS
|
ral guanine nucleotide dissociation stimulator
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RAP1B
|
RAP1B, member of RAS oncogene family
|
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RASA2
|
RAS p21 protein activator 2
|
|
RASA3
|
RAS p21 protein activator 3
|
|
RASA4
|
RAS p21 protein activator 4
|
|
RASA4B
|
RAS p21 protein activator 4B
|
|
RASAL1
|
RAS protein activator like 1 (GAP1 like)
|
|
RASAL2
|
RAS protein activator like 2
|
|
RASAL3
|
RAS protein activator like 3
|
|
RASGRF1
|
Ras protein-specific guanine nucleotide-releasing factor 1
|
|
RASGRF2
|
Ras protein-specific guanine nucleotide-releasing factor 2
|
|
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated)
|
|
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated)
|
|
RASGRP3
|
RAS guanyl releasing protein 3 (calcium and DAG-regulated)
|
|
RASGRP4
|
RAS guanyl releasing protein 4
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RGL1
|
ral guanine nucleotide dissociation stimulator-like 1
|
|
RGL2
|
ral guanine nucleotide dissociation stimulator-like 2
|
|
RHOA
|
ras homolog family member A
|
|
RIN1
|
Ras and Rab interactor 1
|
|
RRAS
|
related RAS viral (r-ras) oncogene homolog
|
|
RRAS2
|
related RAS viral (r-ras) oncogene homolog 2
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SHC2
|
SHC (Src homology 2 domain containing) transforming protein 2
|
|
SHC3
|
SHC (Src homology 2 domain containing) transforming protein 3
|
|
SHC4
|
SHC (Src homology 2 domain containing) family, member 4
|
|
SHOC2
|
soc-2 suppressor of clear homolog (C. elegans)
|
|
SOS1
|
son of sevenless homolog 1 (Drosophila)
|
|
SOS2
|
son of sevenless homolog 2 (Drosophila)
|
|
STK4
|
serine/threonine kinase 4
|
|
SYNGAP1
|
synaptic Ras GTPase activating protein 1
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TTBK1
|
tau tubulin kinase 1
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
